For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Geron Corp (NASDAQ: GERN) was $4.22 for the day, down -0.71% from the previous closing price of $4.25. In other words, the price has decreased by -$0.71 from its previous closing price. On the day, 6.03 million shares were traded. GERN stock price reached its highest trading level at $4.32 during the session, while it also had its lowest trading level at $4.12.
Ratios:
Our analysis of GERN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.60 and its Current Ratio is at 3.61. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.13.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on Nov-06-24, initiated with a Buy rating and assigned the stock a target price of $8.
On September 09, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $7.Leerink Partners initiated its Outperform rating on September 09, 2024, with a $7 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 08 ’24 when GRETHLEIN ANDREW J sold 674,348 shares for $4.56 per share. The transaction valued at 3,073,004 led to the insider holds 0 shares of the business.
Feller Faye sold 287,900 shares of GERN for $1,334,129 on Jun 10 ’24. The EVP, Chief Medical Officer now owns 0 shares after completing the transaction at $4.63 per share. On Jun 10 ’24, another insider, Kapur Anil, who serves as the EVP, Corp Strategy & CCO of the company, sold 421,875 shares for $4.64 each. As a result, the insider received 1,959,609 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GERN now has a Market Capitalization of 2561881856 and an Enterprise Value of 2268105216. For the stock, the TTM Price-to-Sale (P/S) ratio is 1856.79 while its Price-to-Book (P/B) ratio in mrq is 8.27. Its current Enterprise Value per Revenue stands at 1651.934 whereas that against EBITDA is -10.002.
Stock Price History:
Over the past 52 weeks, GERN has reached a high of $5.34, while it has fallen to a 52-week low of $1.64. The 50-Day Moving Average of the stock is -2.52%, while the 200-Day Moving Average is calculated to be 12.00%.
Shares Statistics:
GERN traded an average of 7.97M shares per day over the past three months and 6059010 shares per day over the past ten days. A total of 602.80M shares are outstanding, with a floating share count of 552.62M. Insiders hold about 8.32% of the company’s shares, while institutions hold 69.77% stake in the company. Shares short for GERN as of 1728950400 were 78825285 with a Short Ratio of 9.89, compared to 1726185600 on 71507757. Therefore, it implies a Short% of Shares Outstanding of 78825285 and a Short% of Float of 13.149999000000001.
Earnings Estimates
A detailed examination of Geron Corp (GERN) is currently in progress, with 9.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.04 and low estimates of -$0.11.
Analysts are recommending an EPS of between -$0.31 and -$0.4 for the fiscal current year, implying an average EPS of -$0.34. EPS for the following year is -$0.13, with 8.0 analysts recommending between $0.12 and -$0.4.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 8 analysts. It ranges from a high estimate of $22.46M to a low estimate of $14.8M. As of the current estimate, Geron Corp’s year-ago sales were $164kFor the next quarter, 8 analysts are estimating revenue of $37.36M. There is a high estimate of $55.8M for the next quarter, whereas the lowest estimate is $18.31M.
A total of 9 analysts have provided revenue estimates for GERN’s current fiscal year. The highest revenue estimate was $78.1M, while the lowest revenue estimate was $35.5M, resulting in an average revenue estimate of $57.32M. In the same quarter a year ago, actual revenue was $237kBased on 9 analysts’ estimates, the company’s revenue will be $274.71M in the next fiscal year. The high estimate is $452.3M and the low estimate is $95.5M.
